Chai Discovery closes $130M Series B at $1.3B valuation

Chai Discovery/Chai-2

Chai Discovery announced a $130M Series B round co-led by Oak HC/FT and General Catalyst at a $1.3B valuation. The funding supports commercial partnerships with major pharmaceutical companies and clinical validation of AI-designed antibodies.